Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments

Toxicon

Volumn 72, Issue , 2013, Pages 29-34

  Yermakova, Anastasiya ^a,b   Mantis, Nicholas J ^a,b  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY AT ALBANY   (United States)

Author keywords

Biodefense; Mouse; Neutralizing antibodies; Toxin

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 24B11; MONOCLONAL ANTIBODY SYLH3; RICIN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CELL ASSAY; CONTROLLED STUDY; IMMUNITY; IN VITRO STUDY; PRIORITY JOURNAL;

BIODEFENSE; MOUSE; NEUTRALIZING ANTIBODIES; TOXIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTITOXINS; IMMUNOGLOBULIN FAB FRAGMENTS; MICE; RICIN; TOXICITY TESTS;

EID: 84880097159     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2013.04.005     Document Type: Article

References (34)

1. Abboud N., Chow S.K., Saylor C., Janda A., Ravetch J.V., Scharff M.D., Casadevall A. A requirement for FcgammaR in antibody-mediated bacterial toxin neutralization. J. Exp. Med. 2010, 207:2395-2405.
2. Bazin-Redureau M.I., Renard C.B., Scherrmann J.M. Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab')2 and Fab after intravenous administration in the rat. J. Pharm. Pharmacol. 1997, 49:277-281.
3. Harvill E.T., Osorio M., Loving C.L., Lee G.M., Kelly V.K., Merkel T.J. Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors. Infect. Immun. 2008, 76:2177-2182.
4. Jandhyala D.M., Thorpe C.M., Magun B. Ricin and Shiga toxins: effects on host cell signal transduction. Curr. Top. Microbiol. Immunol. 2012, 357:41-65.
5. Jones R.G., Alsop T.A., Hull R., Tierney R., Rigsby P., Holley J., Sesardic D. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays. Toxicon 2006, 48:246-254.
6. Kim J., Bronson C.L., Wani M.A., Oberyszyn T.M., Mohanty S., Chaudhury C., Hayton W.L., Robinson J.M., Anderson C.L. Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn-alpha-chain deficient mice. Exp. Biol. Med. (Maywood) 2008, 233:603-609.
7. Mabry R., Rani M., Geiger R., Hubbard G.B., Carrion R., Brasky K., Patterson J.L., Georgiou G., Iverson B.L. Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infect. Immun. 2005, 73:8362-8368.
8. Maddaloni M., Cooke C., Wilkinson R., Stout A.V., Eng L., Pincus S.H. Immunological characteristics associated with the protective efficacy of antibodies to ricin. J. Immunol. 2004, 172:6221-6228.
9. Maynard J.A., Maassen C.B., Leppla S.H., Brasky K., Patterson J.L., Iverson B.L., Georgiou G. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat. Biotechnol. 2002, 20:597-601.
10. McGuinness C.R., Mantis N.J. Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit. Infect. Immun. 2006, 74:3463-3470.
11. Montfort W., Villafranca J.E., Monzingo A.F., Ernst S.R., Katzin B., Rutenber E., Xuong N.H., Hamlin R., Robertus J.D. The three-dimensional structure of ricin at 2.8 A. J. Biol. Chem. 1987, 262:5398-5403.
12. Mukherjee J., Tremblay J.M., Leysath C.E., Ofori K., Baldwin K., Feng X., Bedenice D., Webb R.P., Wright P.M., Smith L.A., Tzipori S., Shoemaker C.B. A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model. PLoS One 2012, 7:e29941.
13. Neal L.M., O'Hara J., Brey R.N., Mantis N.J. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin. Infect. Immun. 2010, 78:552-561.
14. Newton D.L., Wales R., Richardson P.T., Walbridge S., Saxena S.K., Ackerman E.J., Roberts L.M., Lord J.M., Youle R.J. Cell surface and intracellular functions for ricin galactose binding. J. Biol. Chem. 1992, 267:11917-11922.
15. Nowakowski A., Wang C., Powers D.B., Amersdorfer P., Smith T.J., Montgomery V.A., Sheridan R., Blake R., Smith L.A., Marks J.D. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11346-11350.
16. O'Hara J.M., Neal L.M., McCarthy E.A., Kasten-Jolly J.A., Brey R.N., Mantis N.J. Folding domains within the ricin toxin A subunit as targets of protective antibodies. Vaccine 2010, 28:7035-7046.
17. O'Hara J.M., Whaley K., Pauly M., Zeitlin L., Mantis N.J. Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit. Vaccine 2012, 30:1239-1243.
18. O'Hara J.M., Yermakova A., Mantis N.J. Immunity to ricin: fundamental insights into toxin-antibody interactions. Curr. Top. Microbiol. Immunol. 2012, 357:209-241.
19. Pincus S.H., Eng L., Cooke C.L., Maddaloni M. Identification of hypoglycemia in mice as a surrogate marker of ricin toxicosis. Comp. Med. 2002, 52:530-533.
20. Roche J.K., Stone M.K., Gross L.K., Lindner M., Seaner R., Pincus S.H., Obrig T.G. Post-exposure targeting of specific epitopes on ricin toxin abrogates toxin-induced hypoglycemia, hepatic injury, and lethality in a mouse model. Lab. Invest. 2008, 88:1178-1191.
21. Rutenber E., Ready M., Robertus J.D. Structure and evolution of ricin B chain. Nature 1987, 326:624-626.
22. Rutenber E., Robertus J.D. Structure of ricin B-chain at 2.5 A resolution. Proteins 1991, 10:260-269.
23. Sandvig K., Olsnes S., Pihl A. Kinetics of binding of the toxic lectins abrin and ricin to surface receptors of human cells. J. Biol. Chem. 1976, 251:3977-3984.
24. Sepulveda J., Mukherjee J., Tzipori S., Simpson L.L., Shoemaker C.B. Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents. Infect. Immun. 2010, 78:756-763.
25. Spooner R.A., Lord J.M. How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr. Top. Microbiol. Immunol. 2012, 357:19-40.
26. Swimmer C., Lehar S.M., McCafferty J., Chiswell D.J., Blattler W.A., Guild B.C. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:3756-3760.
27. Ujhelyi M.R., Robert S. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity. Clin. Pharmacokinet. 1995, 28:483-493.
28. Vance D.J., Mantis N.J. Resolution of two overlapping neutralizing B cell epitopes within a solvent exposed, immunodominant alpha-helix in ricin toxin's enzymatic subunit. Toxicon 2012, 60:874-877.
29. Verma A., Ngundi M.M., Meade B.D., De Pascalis R., Elkins K.L., Burns D.L. Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays. Clin. Vaccine Immunol. 2009, 16:1405-1412.
30. Vitale L., Blanset D., Lowy I., O'Neill T., Goldstein J., Little S.F., Andrews G.P., Dorough G., Taylor R.K., Keler T. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity. Infect. Immun. 2006, 74:5840-5847.
31. Wild M.A., Xin H., Maruyama T., Nolan M.J., Calveley P.M., Malone J.D., Wallace M.R., Bowdish K.S. Human antibodies from immunized donors are protective against anthrax toxin invivo. Nat. Biotechnol. 2003, 21:1305-1306.
32. Yermakova A., Mantis N.J. Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB). Vaccine 2011, 29:7925-7935.
33. Yermakova A., Vance D.J., Mantis N.J. Sub-domains of ricin's B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies. PLoS One 2012, 7:e44317.
34. Zentz C., Frenoy J.P., Bourrillon R. Binding of galactose and lactoseto ricin. Equilibrium studies. Biochim. Biophys. Acta 1978, 536:18-26.